Avacta Life Sciences Group Plc (www.avacta.com) is a small-cap biotech company. Two key divisions support the health company: Oncology drug development (Therapeutics) and Diagnostics. The latter is about expanding the in-vitro diagnostics business to support the medical profession; while the former is about leveraging its proprietary pre|CISION and Affirmer platforms to develop cancer therapies. What makes Avacta
Today’s Avacta share price is 135p (as of 01/12/2023 16:37) which is a change of -2 or -1.46% from the last closing price of 135 with 787,588 shares traded giving Avacta a market capitalisation of £382,878,900. The most recent daily high has been 138.3 and daily low 134.06. The Avacta share price 52 week high has been 187.98 and the 52 week low 87.99. Based on the most recent Avacta share price opening of 135, the current Avacta EPS (earnings per share) are 0.16 and the PE (price earnings ratio) is n/a.